Cargando…
Non‐alcoholic fatty liver disease and type 2 diabetes: An update
The global prevalence of non‐alcoholic fatty liver disease (NAFLD) is rising, along with the epidemic of diabesity. NAFLD is present in >70% of individuals with type 2 diabetes. Although the mutually detrimental relationship between NAFLD and type 2 diabetes has been well established, a multitude...
Autores principales: | Lee, Chi‐H, Lui, David TW, Lam, Karen SL |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153839/ https://www.ncbi.nlm.nih.gov/pubmed/35080136 http://dx.doi.org/10.1111/jdi.13756 |
Ejemplares similares
-
In search of the optimal management strategy for non‐alcoholic fatty liver disease in type 2 diabetes patients
por: Lee, Chi‐Ho, et al.
Publicado: (2020) -
Managing non‐alcoholic fatty liver disease in diabetes: Challenges and opportunities
por: Lee, Chi‐Ho, et al.
Publicado: (2016) -
Assessing liver fibrosis in all patients with type 2 diabetes and fatty liver disease: It's time to act now
por: Lee, Chi Ho, et al.
Publicado: (2022) -
Glycogenic hepatopathy as an unusual etiology of deranged liver function in a patient with type 1 diabetes: A case report
por: Lui, David TW, et al.
Publicado: (2019) -
Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA
por: Cheung, Ching-Lung, et al.
Publicado: (2014)